
US FDA approves Gilead's twice-yearly injection for HIV prevention
World 15:07 19/06/2025The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.

Exclusive: Trial of Gilead's potential coronavirus treatment running ahead of schedule, researcher says
World 08:00 25/04/2020Details from a Chinese remdesivir trial in patients with severe COVID-19 inadvertently released by the WHO suggested it provided no benefit